Hartline Investment Corp’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,099	Closed	-$1.04M	–	142
2024 Q1	$1.04M	Buy	19,099 +15,181	+387%	+$773K	0.18%	123
2023 Q4	$201K	Hold	3,918	–	–	0.03%	104
2023 Q3	$227K	Hold	3,918	–	–	0.04%	99
2023 Q2	$251K	Sell	3,918 -320	-8%	-$21.5K	0.04%	97
2023 Q1	$294K	Hold	4,238	–	–	0.06%	93
2022 Q4	$305K	Buy	+4,238	New	+$320K	0.07%	92
2022 Q3	–	Sell	-26,623	Closed	-$1.65M	–	160
2022 Q2	$1.65M	Buy	26,623 +13,457	+102%	+$1.02M	0.24%	56
2022 Q1	$880K	Buy	13,166 +3,518	+36%	+$236K	0.11%	79
2021 Q4	$602K	Sell	9,648 -3,255	-25%	-$191K	0.08%	80
2021 Q3	$763K	Sell	12,903 -263	-2%	-$17.3K	0.11%	83
2021 Q2	$880K	Sell	13,166 -2,167	-14%	-$141K	0.11%	79
2021 Q1	$968K	Sell	15,333 -11,290	-42%	-$702K	0.15%	73
2020 Q4	$1.65M	Sell	26,623 -7,817	-23%	-$481K	0.24%	56
2020 Q3	$2.08M	Sell	34,440 -32,937	-49%	-$1.98M	0.35%	45
2020 Q2	$3.96M	Sell	67,377 -9,299	-12%	-$556K	0.83%	29
2020 Q1	$4.27M	Sell	76,676 -1,565	-2%	-$95.7K	1.07%	23
2019 Q4	$5.02M	Buy	+78,241	New	+$4.48M	1.08%	24